+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Laboratory Services - Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles

  • ID: 2789625
  • Report
  • December 2013
  • Region: Global
  • 200 Pages
  • Kalorama Information
1 of 4
Clinical Lab Services Industry Strives To Grow Despite Large Reimbursement Cuts

FEATURED COMPANIES

  • Clarient, Inc.
  • DaVita
  • Genomic Health
  • Genoptix, Inc.
  • Genzyme Corporation
  • Quest Diagnostics, Inc.
  • MORE
The market for clinical lab services is dynamic. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers.

There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter.

Clinical Laboratory Services (Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles), provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report.

Key market data provided:

- Hospital, Physician and Independent Lab Statistics

- Major Tests Performed by Clinical Lab Companies

- Disease Incidence and Trends Driving Lab Business

- Market Forecast to 2018

- Geographic Breakout of Clinical Lab Services Market (includes US, Europe Asia with specific breakouts for Germany, Japan, China, India and Brazil)

- Market Breakdown by Lab Type (Hospital, Physician, Independent)

- Market Breakdown by Test Type (Specialty, Routine)

- US Market Share of Competitors

- Competitive Analysis of Leading clinical Lab Providers

A trend towards preventive and risk factor testing has been noted in several disciplines, particularly in the areas of oncology, endocrinology, and gynecology. Physicians in these areas are taking full advantage of testing for early detection and disease prevention.

Some of the other issues and trends explored in this study include:

- U.S. Demographics
- Types of Specialty Tests
- Growing Competition
- Increasing Life Expectancy
- Growing Incidence of Disease
- New Product Offerings
- Regulatory Environment
- Insurance and Reimbursement
- Payer Types
- Developments in Personalized Medicine

Historical data was provided for the years 2008- 2012, with forecast data provided for 2013 through 2017. A competitive analysis is provided for the year 2013. The forecasted market analysis for 2013-2017 was largely based on demographic trends, new developments, company performance trends, mergers and acquisitions, and national expansion.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Clarient, Inc.
  • DaVita
  • Genomic Health
  • Genoptix, Inc.
  • Genzyme Corporation
  • Quest Diagnostics, Inc.
  • MORE
1. Executive Summary

- Industry At A Glance
- Scope And Methodology
- World Market Summary
- The U.S. Clinical Laboratory Market
- Key Issues And Trends Affecting The Market
- Leading Market Participants

2. Industry Overview

- Clinical Laboratory Description
- Testing And Services
Routine Testing
Blood Cell Count
Cholesterol Level Testing
Hiv Testing
Pap Testing
Pregnancy Testing
Substance Abuse Testing
Urinalysis
Specialty Testing
Endocrinology
Esoteric Testing
Genetics
Immunology And Molecular Microbiology
Oncology
Serology
Toxicology
Industry Structure
HospitalBased Laboratories
U.S. Hospital Data
U.S. Hospital Stay Stats
International Hospital/Acute Care Data
International Hospital Stay Stats
PhysicianOffice Laboratories
Number Of U.S. Physicians
Independent Clinical Laboratories

3. CLIA Laboratory Registration, Laboratories By Type
Issues And Trends In The Clinical Laboratory Industry

- Issues And Trends Overview
- Demographics
Global Demographics
Global Population Over Age 65
U.S. Demographics
U.S. Population Over Age 65
Life Expectancy
- Incidence Of Diseases
- Surgical Procedure Volumes
- Regulatory Overview
Certificate Of Waiver
Certificate Of Provider-Performed Microscopy Procedures (Ppmp)
Certificate Of Compliance And Certificate Of Accreditation
States Exempt From Federal Clinical Laboratory Improvements Amendments (Clia) Of 1988
- Insurance And Reimbursement
Laboratory Service Payer Types
Trends In Medicare Reimbursement
Health Care Reform
Bundled Insurance Payments For Esrd Patients
Hippa
Commercial Insurance Providers
- New Developments In Information Technology

4. Leading Market Participants

- Summary
- Bio-Reference Laboratories
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Locations
- Clarient, Inc. (A Ge Healthcare Company)
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Locations
- Davita Healthcare Partners, Inc.
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Locations
- Genomic Health, Inc.
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Locations
- Genoptix, Inc.
Company Overview
Performance Review
Products And Services
Growth Strategy
Locations
- Laboratory Corporation Of America
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Locations
- Myriad Genetics, Inc.
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Locations
- Quest Diagnostics, Inc.
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Business Locations
- Spectra Laboratories
Company Overview
Performance Review
Key Acquisitions, Alliances, And Partnerships
Products And Services
Growth Strategy
Locations

5. Market Trends And Summary

- World Market Overview
- U.S. Market Overview
Market Analysis By Laboratory Type
Hospital-Based Clinical Laboratory Segment
Independent Laboratory Segment
Physician-Office Laboratory Segment
Market Analysis By Test Type
Routine Testing
Specialty Testing
- U.S. Competitive Analysis
- International Market Overview
International Markets And Trends
Asia Pacific
Europe And Middle East
Latin America

List Of Major Companies And Organizations
State Clia Offices

List Of Exhibits

Table 1-1 World Clinical Laboratory Market Analysis, 2008-2018
Figure 1-1 World Clinical Laboratory Market Analysis: 2008-2018
Table 1-2 U.S. Clinical Laboratory Market Analysis, 2008-2018
Figure 1-2 U.S. Clinical Laboratory Market Analysis: 2008-2018
Figure 1-3 Leading Market Participant Revenues, 2012* ($Millions) Industry Overview
Table 2-1 Laboratory Reference Parameters For Cbc
Table 2-2 High Cholesterol Risk Categories
Table 2-3 Hcg Levels In Pregnant Women By Days Past Ovulation
Table 2-4 Substance Detection Periods By Test Method
Table 2-5 Normal Reference Levels In A Medical Urinalysis
Figure 2-1 Growth In Clinical Laboratories, 1997-2013
Table 2-6 U.S. Registered Hospitals By Type, 2008 Through 2011
Figure 2-2 Distribution Of U.S. Registered Hospitals By Type, 2011
Figure 2-3 Number Of Hospitals In The U.S., 1975-2005, Estimated 2015
Table 2-7 Statistics For U.S. Hospitals, 2011
Table 2-8 Leading For-Profit U.S. Hospital Chains, 2010 And 2012
Table 2-9 U.S. Hospital Length Of Stay, Average By Age Group
Figure 2-4 U.S. Hospital Length Of Stay, Average By Age Group
Table 2-10 Registered Hospitals And Acute Care Centers By Country
Figure 2-5 Registered Hospitals And Acute Care Centers By Country
Table 2-11 Average International Length Of Stay For Acute Care Centers, By Country 2011
Figure 2-6 Average International Length Of Stay, By Country 2011
Table 2-12 Physicians In The U.S. By Specialty, 1970-2010
Figure 2-7 Number Of Physician Offices, United States, 2000-2009
Table 2-13 Medical Doctors Per 1,000 Population By Country, 2011
Figure 2-8 Medical Doctors Per 1,000 Population By Country, 2011
Table 2-14 Leading U.S. Independent Laboratory Groups, Mid-2013
Figure 2-9 Leading U.S. Independent Laboratory Groups, Distribution Of Centers, Mid-2013
Figure 2-10 U.S. Clia Clinical Laboratory Registration By Primary Laboratory Type: 6/2013
Table 2-15 Clia Registered Laboratories By Type Of Facility (Exempt/Non-Exempt Combined) June 2013
Figure 2-11 Change In Clia Registered Laboratories By Type Of Facility (Exempt/Non-Exempt Combined) June 2011 Versus June 2013 Issues And Trends In The Clinical Laboratory Industry
Table 3-1 The Global Population, 1980-2050
Figure 3-1 The Global Population, 1980-2050
Table 3-2 Global Population Trends Age 65+, 2000-2050
Figure 3-2 Global Population Trends Age 65+, 2000-2050
Table 3-3 The U.S. Population, 1980-2050
Figure 3-3 The U.S. Population, 1980-2050
Table 3-4 Percent U.S. Population Over Age 65 By Year, 2000-2050
Figure 3-4 United States Population Trend Age 65+, 2000-2050
Table 3-5 Average Life Expectancy In Years By Country 1980 And 2012
Figure 3-5 Average Life Expectancy In Years By Country 1980 And 2012
Table 3-6 U.S. Prevalence Of Selected Medical Conditions
Figure 3-6 U.S. Prevalence Of Selected Medical Conditions
Table 3-7 Surgical Procedures In The United States, By Procedure Category, 2010
Table 3-8 Selected Clia Waived Laboratory Tests
Table 3-9 Provider-Performed Microscopy Procedures
Figure 3-7 Clinical Laboratory Certificate Of Accreditation Issued By Organization (Non-Exempt Laboratories Only), June 2013
Table 3-10 Clinical Laboratory Certificates Issued By Type (Non-Exempt Laboratories Only), June 2013
Figure 3-8 Clinical Laboratory Certificates Issued By Selected State (Non-Exempt Laboratories Only), June 2013
Figure 3-9 Clinical Laboratory Certificates Issued By Type (Non-Exempt Laboratories Only), June 2013
Table 3-11 Clia Exempt States, Number Of Laboratories, June 2013
Table 3-12 Health Insurance Trends In The United States, Estimated 2010* (Millions)
Figure 3-10 Health Insurance Coverage In The United States By Type, Estimated 2010*
Table 3-13 U.S. Clinical Laboratory Clients And Payers By Type, 2013 (%)
Figure 3-11 Clinical Laboratory Clients And Payers By Type
Table 3-14 Medicare Reimbursement Trends, 2009 Vs. 2013
Table 3-15 Esrd-Related Laboratory Tests Included In New Bundle Payment Structure
Table 3-16 Comparison Between New Bundled And Composite Medicare Reimbursement Program (1983-2010 And 2011+)
Table 3-17 Leading Commercial Insurance Providers, 2012
Table 3-18 Leading Laboratory Information Management System Providers
Table 3-19 Release Of Laboratory Test Results Directly To Patients, By State
Figure 4-1 Leading Market Participant Revenues, 2012* ($Millions)
Table 4-1 Corporate Details Of Bio-Reference Laboratories
Figure 4-2 Bio-Reference'S Sales To Third Parties, 2008-2012 ($Millions)
Table 4-2 Company Details For Clarient
Figure 4-3 Clarient'S Sales To Third Parties, 2008 And 2009 And Estimated 2010, 2011, And 2012 ($Millions)
Table 4-3 Corporate Details Of Davita
Figure 4-4 Davita'S Revenues, 2008-2012 ($Millions)
Table 4-4 Corporate Details Of Genomic Health
Figure 4-5 Genomic Health'S Sales To Third Parties, 2008-2012 ($Millions)
Table 4-5 Company Details For Genoptix
Figure 4-6 Novartis' Sales To Third Parties, 2008-2012 ($Millions)
Table 4-6 Corporate Details Of Laboratory Corporation Of America
Figure 4-7 Laboratory Corporation Of America'S Sales To Third Parties, 2008-2012 ($Millions)
Table 4-7 Corporate Details For Myriad Genetics
Figure 4-8 Myriad Genetics' Sales To Third Parties, 2008-2012 ($Millions)
Table 4-8 Corporate Details Of Quest Diagnostics
Figure 4-9 Quest Diagnostics' Clinical Testing Sales To Third Parties, 2008-2012 ($Millions)
Table 4-9 Company Details For Spectra Laboratories
Figure 4-10 Fresenius Medical Care Revenues And Estimated Spectra Clinical Testing Sales To Third Parties, 2008-2012 ($Millions)
Table 5-1 World Clinical Laboratory Market Analysis, 2008-2018
Figure 5-1 World Clinical Laboratory Market Analysis: 2008-2018
Table 5-2 U.S. Clinical Laboratory Market Analysis, 2008-2018
Figure 5-2 U.S. Clinical Laboratory Market Analysis: 2008-2018
Table 5-3 U.S. Clinical Laboratory Market Analysis By Laboratory Type, 2008-2018
Figure 5-3 U.S. Clinical Laboratory Market Analysis By Laboratory Type, 2008-2018
Figure 5-4 U.S. Clinical Laboratory Market Share By Laboratory Type, 2013
Figure 5-5 U.S. Clinical Laboratory Market Share By Laboratory Type, 2018
Figure 5-6 U.S. Clinical Laboratory Market Share By Test Type, 2013
Table 5-4 U.S. Clinical Laboratory Market Analysis By Test Type, 2008-2018
Figure 5-7 U.S. Clinical Laboratory Market Analysis By Test Type, 2008-2018
Figure 5-8 U.S. Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2008-2018149
Figure 5-9 U.S. Clinical Laboratory Market Analysis: Specialty Testing By Type, 2013
Figure 5-10 U.S. Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2008-2018152
Table 5-5 Estimated U.S. Laboratory Service Revenues And Market Share Of Leading Clinical Laboratory Providers 2013
Figure 5-11 Estimated U.S. Laboratory Service Revenues And Market Share Of Leading Clinical Laboratory Providers 2013
Figure 5-12 Estimated U.S. Laboratory Service Revenues For Leading Clinical Laboratory Providers 2010 Vs. 2013
Table 5-6 Global Clinical Laboratory Market Analysis, Revenues By Region, 2013
Figure 5-13 Global Clinical Laboratory Market Analysis, Revenues By Region, 2013
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Clarient, Inc.
  • DaVita
  • Genomic Health
  • Genoptix, Inc.
  • Genzyme Corporation
  • Quest Diagnostics, Inc.
  • MORE
Faced with daunting reimbursement cuts and other challenges, the world market for clinical laboratory services grew just over one percent in the past five year. The new report Clinical Laboratory Services estimated the market at $99.1 billion for 2013, up 1.3% from the estimated value in 2008 of $92.7 billion.

The report notes that while there are a number of drivers for this market: aging populations, a growing incidence of chronic diseases, increasing emphasis on diagnosis and disease monitoring, and a growth in advanced testing technologies and practices. However, there are also a number of inhibitors to growth such as the growing emphasis to reduce health costs and uncertain economic conditions, and these are dampening growth.

In the United States, the U.S. Congress ultimately has the responsibility to adjust the Medicare fee schedule according to economic factors, including controlling costs, monitoring utilization, and ensuring adequate delivery of health care services. The passing of the Patient Protection and Affordable Care Act generated a number of provisions on laboratory fee schedules, mostly in the direction of reductions. These reductions were effective starting 2011 and will continue to be adjusted through 2015. Medicare has slashed reimbursement amounts for many common tests such as Vitamin B12, triglycerides and glucose nearly six percent between 2009 and 2013. Some tests, such as total iron or aluminum tests have been cut 19% and 30% respectively during that period.

Bio-Reference Laboratories, Quest, Lab Corp, Myriad, and Spectra are among the leaders in the industry. Quest Diagnostics and LabCorp have advantages in the market due to the wide exposure, large number of locations, and greater financial positions. Smaller, independent laboratories may find it difficult to keep up with the fast changing industry largely due to limited financial abilities to invest in new technologies and testing services. Some laboratories, such as Bio-Reference Labs have found success in operating on a regional basis while companies such as Myriad Genetics and Genomic Health remain competitive by focusing on more specialized genetic-based testing.
Note: Product cover images may vary from those shown
5 of 4
- Bio-Reference Laboratories
- Clarient, Inc.
- DaVita
- Genomic Health
- Genoptix, Inc.
- Genzyme Corporation
- Laboratory Corporation of America (LabCorp)
- Quest Diagnostics, Inc.
- Spectra Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll